Base stable semipermeable membrane and methods thereof
10335745 ยท 2019-07-02
Assignee
Inventors
- Polina Lapido (Rishon Le Zion, IL)
- Vera Ginzburg (Rehovot, IL)
- Hagit Shalev (Ashdod, IL)
- Boris Ginzburg (Rehovot, IL)
Cpc classification
B01D2323/08
PERFORMING OPERATIONS; TRANSPORTING
B01D69/02
PERFORMING OPERATIONS; TRANSPORTING
B01D69/125
PERFORMING OPERATIONS; TRANSPORTING
B01D71/58
PERFORMING OPERATIONS; TRANSPORTING
B01D2325/20
PERFORMING OPERATIONS; TRANSPORTING
B01D71/68
PERFORMING OPERATIONS; TRANSPORTING
International classification
B01D61/02
PERFORMING OPERATIONS; TRANSPORTING
B01D67/00
PERFORMING OPERATIONS; TRANSPORTING
B01D69/02
PERFORMING OPERATIONS; TRANSPORTING
B01D69/12
PERFORMING OPERATIONS; TRANSPORTING
B01D71/68
PERFORMING OPERATIONS; TRANSPORTING
Abstract
The present invention provides a semipermeable membrane having enhanced alkaline stability and a method of forming a semipermeable membrane having enhanced alkaline stability, comprising steps of: providing an ultrafiltration (UF) base membrane, immersing said UF membrane in a solution comprising at least one substance selected from the group consisting of a polymer preferably polyethylenimine (PEI), a condensate solution and a mixture thereof, thereby forming reactive moieties upon said UF membrane, and forming at least one first layer upon at least portion of said UF base support membrane by immersing said UF base support membrane of step (b) in a solution comprising at least one ingredient selected from the group consisting of polymer preferably polyethylenimine (PEI), condensate solution and a mixture thereof thereby forming a cross-linked skin on the surface of said base membrane.
Claims
1. A base stable semipermeable nanofiltration (NF) membrane, wherein said NF membrane is prepared by a process comprising steps of: a. providing an ultrafiltration (UF) base support membrane selected from the group consisting of polyethersulfone (PES) and polysulfone (PS); said UF base membrane is a non-crosslinked base polymer; b. providing a modification solution comprising water soluble partially crosslinked polyethylenimine (PEI) or non-crosslinked PEI; c. activating the surface of said UF membrane by subjecting said UF membrane to heating in an aqueous solution containing 0.1% (w/w) of the condensate of cyanuric chloride with sulfanilic acid for 1 hour at a temperature of 70 C.; d. forming a first crosslinked layer upon at least a portion of a surface of said UF base support membrane of step (c); said forming comprises steps of: i. providing said modification solution to comprise 1% (w/w) water soluble partially crosslinked PEI or 1% (w/w) oligomer-polymer mixture of water soluble non-crosslinked PEI (PEI MW 800 and PEI MW 750K at a ratio of 1:1); ii. preparing said modification solution to comprise partially crosslinked PEI by admixing an aqueous solution of said condensate of cyanuric chloride with sulfanilic acid within an aqueous solution of said PEI oligomer-polymer mixture at a ratio of said condensate to said PEI being 0.3:1.0, with subsequent heating of said modification solution at 50 C. for 3 hours; iii. immersing said UF base support membrane in said prepared 1% (w/w) modification solution to comprise a partially crosslinked PEI, for 18 hours at a room temperature, then subsequent heat-treating said membrane in either modification solution for 1 hour at 50 C. or in prepared 1% (w/w) solution comprising oligomer-polymer mixture of non-crosslinked PEI (PEI MW 800 and PEI MW 750K at a ratio of 1:1) for 1 hour at 90 C.; iv. after cooling and washing, contacting said UF base support membrane of step (iii) with aqueous solution comprising 0.1% w/w of the condensate of cyanuric chloride with sulfanilic acid for 1 hour at room temperature; and v. curing said UF base support membrane of step (iv) in an alkaline solution, pH=11, for 2 hours at 70 C. to complete the formation of the first cross-linked layer upon of said activated UF base support membrane; e. forming a second crosslinked layer upon said first layer of said UF base support membrane of step (d) comprising steps of: i. providing a modification solution comprising water soluble partially crosslinked PEI prepared according to step (d, ii) and diluted to either concentration of 0.125% (w/w) or 0.125% (w/w) of non-crosslinked PEI, prepared from PEI, MW 750K; ii. contacting said UF base support membrane of step (d, v) with an aqueous solution comprising 0.1% w/w of the condensate of cyanuric chloride with sulfanilic acid for 1 hour at room temperature; iii. immersing said UF base support membrane of step (ii) in 0.125% (w/w) modification solution for 1 hour at room temperature for partially crosslinked PEI or alternatively at 90 C. for non-crosslinked PEI; iv. heat-treatment of said UF base support membrane in alkaline solution, pH=11, for 2-3 hours at 60-90 C.; v. cooling and rinsing said UF base support membrane with reverse osmosis (RO) water; vi. immersing said UF membrane of step (v) in an aqueous solution comprising 0.1% w/w of the condensate of cyanuric chloride with sulfanilic acid for 1 hour at room temperature; and, vii. heat-treating in an alkaline solution, pH=11, for 2 hours at 60 C., followed by 2 hours at 90 C. to complete the formation of the second crosslinked layer upon said UF membrane with said first crosslinked layer, said second crosslinked layer is a NF layer; f. repeating said step (e) n times for providing NF membrane with n+1 multiple cross-linked layers upon said first layer of said UF base support membrane; n is an integer number equals to or greater than 1; and, g. immersing said base stable semipermeable NF membrane in 20% solution of phosphoric acid in water at a temperature ranging from 70 C. to 90 C. for a period of time ranging from 18 to 24 hours.
2. The base stable semipermeable NF membrane according to claim 1, wherein the following holds true: a. said step (a) of providing UF base support membrane is with molecular weight cut-off (MWCO) in the range of 5 kD to 30 kD; b. said step (c) of subjecting said UF support membrane to heating before forming the first NF layer in aqueous solution containing 0.05 to 0.3% w/w of condensate of cyanuric chloride with sulfanilic acid for a period of time ranging from 1 to 3 hours at a temperature of not more than 70 C.; and, c. said NF membrane is stable in an environment having a pH in the range of 2 to 14.
3. The base stable semipermeable NF membrane according to claim 1, wherein the following holds true: a. said NF membrane, after soak testing with 20%.sub.w/wNaOH in water at 40 C., yields more than 97% glucose rejection; b. said NF membrane, when exposed to 20% w/w NaOH solution at 40 C. for 130 days, maintains the initial performance with glucose rejection of 97%; c. said NF membrane, when exposed to 10% w/w NaOH solution at 70 C. for 450 hours, removes 97% of Cu(ETDA) at a flux greater than 21 LMH from a feed solution of 0.4% w/w Cu(ETDA) in 10% NaOH when the feed solution is applied to said NF layer at a feed pressure of 30 bar and a temperature of 25 C.; and, d. said NF membrane, when exposed to 1% w/v NaAlO.sub.2 in 3.5% w/w NaOH solution as feed, at a feed pressure of 15 bars and a temperature of 40 C. for 240 hours, removes 85.4% of impurities as NaAlO.sub.2.
4. The base stable semipermeable NF membrane according to claim 1, wherein said NF membrane comprising multiple crosslinked layers, said crosslinked layers comprising a matrix which is bound to said UF base support membrane, said matrix has been formed from at least one di-, tri- or tetra-halo substituted diazine or triazine-containing monomer, oligomer or polymer, and at least one multifunctional amine having a molecular weight in the range of about 400 to about 750,000, provided that at least one of the di-, tri- or tetra-halo substituted diazine or triazine-containing monomer, oligomer or polymer is not a di- or triazine monomer which is substituted only by Cl, and any combination thereof; said diazine or triazine-containing monomer or oligomer is selected from the group consisting of: ##STR00005## said R.sup.1 is independently selected at each occurrence from bromo, chloro, iodo, fluoro, NHR.sup.5, OR.sup.5 and SR.sup.5, wherein R.sup.5 is independently selected at each occurrence from H, optionally substituted alkyl and optionally substituted aryl; R.sup.2 is independently selected at each occurrence from bromo, chloro, fluoro, NHR.sup.5, OR.sup.5 and SR.sup.5, wherein R.sup.5 is independently selected at each occurrence from H, optionally substituted alkyl and optionally substituted aryl; R.sup.3 is independently selected at each occurrence from bromo, chloro, fluoro, NHR.sup.5, OR.sup.5 and SR.sup.5, wherein R.sup.5 is independently selected at each occurrence from H, optionally substituted alkyl and optionally substituted aryl; R.sup.4 is selected from H, bromo, chloro, fluoro, NHR.sup.5, OR.sup.5 and SR.sup.5, wherein R.sup.5 is independently selected at each occurrence from H, optionally substituted alkyl and optionally substituted aryl; and R.sup.8 is independently selected at each occurrence from NH.sup.2 and NH-A-NH, wherein A is selected from C.sub.1-20 aliphatic moieties, C.sub.6-10 aromatic moieties, and combinations thereof; provided that at at least two occurrences, R.sup.1, R.sup.2, R.sup.3 and R.sup.4, taken together, are selected from bromo, chloro and fluoro, and further provided that when both R.sup.1 and R.sup.2 on a single ring are Cl, at least one of R.sup.3 and R.sup.4 is not Cl.
5. The base stable semipermeable nanofiltration (NF) membrane of claim 1, wherein said first crosslinked layer is electrostatically bound to said base membrane.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) In the following description of the preferred embodiments, reference is made to the accompanying drawings that form a part hereof, and in which are shown by way of illustration specific embodiments in which the invention may be practiced. It is understood that other embodiments may be utilized and structural changes may be made without departing from the scope of the present invention. The present invention may be practiced according to the claims without some or all of these specific details. For the purpose of clarity, technical material that is known in the technical fields related to the invention has not been described in detail so that the present invention is not unnecessarily obscured.
(2) In the accompanying drawing:
(3)
(4)
(5)
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
(6) The present invention has been defined specifically to provide products methods and means for preparing an alkaline stable semipermeable membrane.
(7) The semipermeable membrane comprises ultrafiltration (UF) base support membrane and a Nanofiltration(NF) membrane. The NF is a layer which is formed over at least a portion of an ultrafiltration (UF) support membrane. Furthermore, the NF layer is bonded to a non-cross-linked base polymer having functional groups. Therefore, the UF base polymer is being modified by encapsuling an NF layer onto the UF base polymer thereof.
(8) The present invention provides a semipermeable membrane with high chemical stability in aggressive operating conditions selected from the group consisting of extreme pH levels, high alkalinity concentrations presence of organic solutions, pressure, temperature and any combination thereof. Alternatively, the semipermeable membrane may be a free-standing membrane.
(9) The membrane of the present invention is characterized by at least one of the following: (i) alkaline stability (10-20% alkaline concentrations) for removing impurities from concentrated mineral bases, (ii) stability in high alkaline conditions for separations in pharmaceutical, chemical and metal industries, (iii) compaction stability under high applied hydrostatic pressures at elevated temperatures, and in the presence of organic solvents for performing separations in many types of industrial wastewater streams, (iv) separating soluble catalysts from organic solvent streams in extreme pH conditions and or highly reactive environments.
(10) In accordance with another preferred embodiment of the present invention, the membrane of the present invention is useful in metal production and Processing, Pharmaceuticals industry, Chemicals industry, Food and Beverage industry, Agricultural industry, Paper and Pulp industry, Rayon industries, Petroleum production, Alkali and/or acid recovery, Metals, organics, Sulfate removal, Chloro-alkali production, Silica removal and Aluminate purification.
(11) In accordance with another preferred embodiment of the present invention, a method of forming a polymeric semipermeable membrane comprising steps of providing a non-cross-linked UF base membrane. The UF membrane is immersed in a condensate solution to form reactive pendant moieties upon the UF membrane. Furthermore, by effecting a cross-linking reaction between the reactive pendant moieties on a surface of the base polymer with an oligomer or another polymer preferably polyethylenimine PEI, thereby forming a cross-linked skin on the surface of the base polymer.
(12) The ultrafiltration membrane is a support polymer having a support (non-woven) polymer preferably polypropylene(PP).
(13) In another embodiment of the present invention Alkalinity or Alkaline refers herein to a soluble base which contains and releases OH.sup. ions quantitatively i.e., a pH higher than 7.0 at standard conditions. Furthermore Alkalinity may further refer to the amount of bases in a solution that can be converted to uncharged species by a strong acid. Alkalinity or A.sub.T further indicates or measures the ability of a solution to neutralize acids to the equivalence point of carbonate or bicarbonate.
(14) The term Semipermeable membranes refers herein to membranes which retain small particulates and microbes having pores size of an average diameter of greater than about 0.1 microns. The upper pore size limitation of microfiltration membranes may be considered to be about 10 microns. Typically, these membranes allow the permeation of smaller components, such as simple salts, dissolved organic materials having a molecular weight of less than about 100,000 and colloidal particles that have physical dimensions that are smaller than pores of MF membrane. Semipermeable membranes possess the highest water permeability of the four classes of membranes, due to their large pore diameters as well as their typical high pore density. The pure water permeability of these membranes is commonly greater than about 5,000 liter/(m.sup.2hbar).
(15) The term ultrafiltration(UF) membrane refers herein to an asymmetric base membrane which at one face thereof has pores of smaller diameter than at the opposite face. The Ultrafiltration (UF) membranes of the present intention are characterized by pore sizes of from about 0.1 micron to about 5 nanometers. UF membranes are commonly classified by their ability to retain specific-sized components dissolved in a solution. This is referred to as the molecular weight cut-off (MWCO). In another embodiments, the UF membranes of the present invention are used to retain proteins, starches, and other relatively large dissolved materials while allowing the permeation of simple salts and smaller dissolved organic compounds. The water permeability of UF membranes is commonly in the range of from about A=100 liter/(m.sup.2hbar) to about A=5000 liter/(m.sup.2hbar).
(16) The term Nanofiltration (NF) membranes refers herein to membranes which possess the ability to fractionate small compounds (i.e., those with molecular weights less than 1000). The small compounds are often salts, and NF membranes are commonly used to permeate monovalent ions while retaining divalent ions.
(17) In another embodiment of the present invention, NF membranes typically possess ionized or ionizable groups on their surfaces, including within the pores. Although not wishing to be bound by theory, it is believed that NF membranes can affect the separation of ionic materials through a charge-based interaction mechanism. NF membranes also can be used to separate uncharged organic compounds, sometimes in solvents other than water or to separate organic molecules from salts. The water permeability of NF membranes is commonly in the range of from about A=I liter/(m.sup.2hbar) to about A=IO liter/(m.sup.2hbar).
(18) The term Reverse osmosis (RO) membranes refers herein to components other than the permeating solvent (usually water). RO membranes, similar to NF membranes, can contain ionic functional groups. RO membranes are commonly used to remove salt from water and to concentrate small organic compounds. The water permeability of reverse osmosis membranes is commonly in the range of from about A=0.2 liter/(mhbar) to about A=5 liter/(m.sup.2hbar). Although the mechanisms that govern membrane performance are not exactly defined, some basic theories have been postulated. A review of some membrane transport theories can be found in The Solution Diffusion Model: A Review, J. G. Wijmans, R. W. Baker, J. Membrane Science, 1995, vol. 107, pp. 1-21, the contents of which are incorporated herein by reference.
(19) The term Condensate refers herein to any molecule or compound which function as a cross-linker agent. The condensate may be a condensation polymer which is formed through a condensation reaction where molecules join togetherlosing small molecules as by-products such as water or methanol, as opposed to addition polymers which involve the reaction of unsaturated monomers. Cationic and anionic polymerization and condensation polymerization systems may also be used to modify the surface layers.
(20) The term about applies hereinafter to a measure being25% of the defined value.
(21) The present invention provides a method of forming a alkaline stable semipermeable membrane comprising the steps of: (a) providing a ultrafiltration (UF) base support membrane, (b) providing a aqueous solution containing condensate, (c) immersing the UF base support membrane in the aqueous solution containing condensate which forms an electrostatic attraction, (d) providing a solution comprising polyethylenimine (PEI), (e) forming at least one first layer upon the UF base support membrane by immersing the UF base support membrane comprising the condensate in the solution comprising PEI for functionalizing the first layer, (f) forming at least one second layer upon the first layer by immersing the PEI with the condensate solution, thereby forming a cross-linked skin on the first layer.
(22) In another embodiment, the steps (a)-(f) may optionally may be repeated n number of times to give multiple crosslinked layers, wherein n is an integer equals to or greater than 1.
(23) In another embodiment of the present invention a method of forming a semipermeable membrane having alkaline stability is provided. The method comprising the steps of providing a UF support membrane such as Polyethersulfone (PES) support membrane. The support membrane may further be subjected to a cleaning step with alkaline solution in reverse osmosis water (ROW). A modification solution was prepared and mixed comprising about 1% polyethylenimine (PEI) and about 0.3% condensate comprising cyanuric chloride and sulfonilic acid. The modification solution was further heated to about 50 C. for about 3 hour. The support membrane may further immersed in the modification solution for about 18 hours at a room temperature (RT), and further heated to about 50 C. for about 1 hour, forming at least one first layer upon at least portion of the UF or PES base support membrane by immersing said UF membrane in the modification solution thereby, forming a cross-linked skin upon the surface of the support membrane. After cooling and rinsing with ROW, the membrane is further immersed in aqueous solution containing 0.1% w/w of the condensate of cyanuric chloride and a sulfanilic acid for about 1 hour. Furthermore, the membrane comprising a first layer may further immersed for the curing step in alkaline solution, pH 11, for 2 hours at 70 C.
(24) In another embodiment of the present invention, the formed crosslinked membrane may further comprise additional layers by optionally repeating the step of immersing the formed membrane in a modification solution n number of times to give multiple crosslinked layers, wherein n is an integer equals to or greater than 1. The repeatable step of immersing is in aqueous solution containing 0.1% w/w of the condensate of cyanuric chloride and a sulfanilic acid for 1 hour, and further comprising immersing in modification solution for 1 hour at RT following with curing step in alkaline solution, pH 11, for 2-3 hours at 70 C. After cooling and rinsing with ROW, the membrane again was immersed in aqueous solution containing 0.1% w/w of the condensate of cyanuric chloride and a sulfanilic acid for 1 hour, then the membrane was immersed in modification for 1 hour at room temperature (RT) and may further be followed with curing step in alkaline solution, pH 11, for 3-4 hours at 60-90 C.
(25) In another embodiment of the present invention, the method of forming an alkaline stable semipermeable membrane further comprising step of actively increasing a cross-linked reaction at room temperature or/and by elevating temperature in the range of about 60-90 C. In another embodiment of the present invention, the formed membrane may further be placed in 20% solution of phosphoric acid in water at 90 C. for a period of about 18 hours.
(26) In another embodiment of the present invention the formed semipermeable membrane may further have a flux of 115 LMH at 40 bar and 98% Glucose retention value.
(27) The present invention provides a alkaline stable semipermeable membrane comprising an ultrafiltration membrane having a base polymer selected from the group consisting of polysulfones, polyether sulfones, polyphenylene sulfones and any combination thereof.
(28) The ultrafiltration membrane having a base polymer is preferably comprising polyehersulfones having MWCO of about 5k-30k, and more preferably 20k.
(29) In another embodiment of the present invention, the base polymer Polysulfone, polyether sulfone and polyphenylene sulfone are known to have very good stability in concentrated alkaline and are thus preferred polymers to be used as polymer.
(30) The method of the present invention further comprising the step of providing a condensate comprising cyanuric chloride and sulfanilic acid. The condensate is chemisorbed within the UF membrane pores using electrostatic attraction.
(31) The method of the present invention further comprising the step of providing a solution comprising polyethylenimine (PEI) thereby, forming a first layer upon the UF membrane comprising the condensate moieties, by immersing the UF base support membrane in a solution comprising PEI.
(32) The present invention further comprising the step of functionalizing at least one first layer by increasing temperature in the range of about 60-70 C. for crosslinking PEI to the condensate reactive pendant moieties,
(33) In another embodiment of the present invention, at least one second layer is formed comprising PEI which is further covalently bonded to the first layer. The method of the present invention, includes the step of layering on at least a portion of the UF base membrane first layer thereby forming a stable composite membrane in feed solution stable in an environment having a pH in the range of about 2 to about 14.
(34) In another embodiment of the present invention, the method additionally comprising steps of curing at least one first layer in alkaline solution having a pH of about 11. The currying procedure provides a chemical treatment such as chemisorption procedure or dissolving procedure in a medium having a desired characteristics such as concentration, pH, pressure, temperature and any combination thereof.
(35) In another embodiment of the present invention, the base supporting UF membrane is encapsulated by PES means thus forming PES encapsulation with PEI and the linked condensate.
(36) The method further includes a membrane modification process with condensate and polyethylenimine (PEI) whilst exposing each separately upon the surface of UF support membrane.
(37) In another embodiments of the present invention the method includes the step of bringing the condensate solution into contact with the at least a portion of the UF membrane having smaller pores for a time sufficient to effect bonding of the at least one di- or tri-halo substituted diazine or triazine-containing monomer, oligomer or polymer and the at least one multifunctional amine. In some embodiments, the multifunctional amine is selected from the group consisting of polyethylenimine, polyvinylamine, polyvinylanilines, polybenzylamines, polyvinylimidazolines, and amine-modified polyepihalohydrins. In some embodiments, the supplemental cross-linker is selected from the group consisting of 2,4,6-trichloro-s-triazine, 4,6-dichloro-2-sodium p-sulfoanile-s-triazine (4,6-dichloro-2-p-anilinesulfonic acid sodium salt-s-triazine), 4,6-dichloro-2-diethanolamine-s-triazine and 4,6-dichloro-2-amino-s-triazine.
(38) The polymeric semipermeable membrane comprises a Nanofiltration(NF) layer formed which is bonded over at least a portion of the UF membrane. The method additionally comprising acid-treatment of the polymeric semipermeable membrane which was formed. The acid treatment includes 20% solution of acid in water at about 90 C. for a period of several hours. In another embodiment of the present invention, the cross-linking reaction includes reacting primary and secondary amino groups with halocarbon groups to form imine and tertiary amino groups.
(39) In another embodiment of the present invention, a method for separating components in a liquid stream being basic or comprising steps of: providing a Semipermeable membrane comprising a Nanofiltration layer characterized by at least one of the following:
(40) (a) the Nanofiltration layer comprises a matrix which is bound to an UF support membrane;
(41) (b) (i) the Nanofiltration layer contains a matrix that has been formed from at least one substrate selected from the group consisting of di-, tri- or tetra-halo substituted diazine or triazine-containing monomer, oligomer or polymer, (ii) at least one multifunctional amine having a molecular weight in the range of 400 to 750,000, provided that at least one of the di-, tri- or tetra-halo substituted diazine or triazine-containing monomer, oligomer or polymer is not a di- or triazine monomer which is substituted only by Cl and any combination thereof,
(42) (c) (i) the Nanofiltration layer, when exposed to 10%.sub.w/w NaOH at 70 C. for 450 hours, removes at least 97% of the impurities at a flux greater than 21 LMH from a feed solution of 0.4%.sub.w/w Cu(ETDA) in 10% NaOH when the feed solution is applied to the membrane at a feed pressure of 30 bar and a temperature of 25 C.,
(43) (ii) after exposure of the Nanofiltration layer to 1% w/v NaAlO.sub.2 at 40 C. for 240 hours, the Nanofiltration layer removes at least 85.4% of the impurities at a flux greater than 42 LMH from a feed solution of 3.5% NaOH when the feed solution is applied to the Nanofiltration layer at a feed pressure of 15 bars and a temperature of 25 C.
(44) In another embodiment of the present invention, preferably operating pressures are in the range of 10-40 bars in the NF applications.
(45) In another embodiment of the present invention, the Nanofiltration layer comprises at least one di-, tri- or tetra-halo substituted diazine or triazine-containing monomer, oligomer or polymer, and at least one multifunctional amine having a molecular weight in the range of 400 to 750,000, provided that at least one of the di-, tri- or tetra-halo substituted diazine or triazine-containing monomer, oligomer or polymer is not a di- or triazine monomer which is substituted only by Cl. Nanofiltration layer optionally comprises at least one supplemental cross-linker.
(46) In another embodiment of the present invention, the di-, tri- or tetra-halo substituted diazine or triazine-containing monomer or oligomer is selected from the group consisting of:
(47) ##STR00004##
wherein;
(48) R.sup.1 is independently selected at each occurrence from bromo, chloro, iodo, fluoro, NHR.sup.5, OR.sup.5 and SR.sup.5, wherein R.sup.5 is independently selected at each occurrence from H, optionally substituted alkyl and optionally substituted aryl;
(49) R.sup.2 is independently selected at each occurrence from bromo, chloro, fluoro, NHR.sup.5, OR.sup.5 and SR.sup.5, wherein R.sup.5 is independently selected at each occurrence from H, optionally substituted alkyl and optionally substituted aryl;
(50) R.sup.3 is independently selected at each occurrence from bromo, chloro, fluoro, NHR.sup.5, OR.sup.5 and SR.sup.5, wherein R.sup.5 is independently selected at each occurrence from H, optionally substituted alkyl and optionally substituted aryl;
(51) R.sup.4 is selected from H, bromo, chloro, fluoro, NHR.sup.5, OR.sup.5 and SR.sup.5, wherein
(52) R.sup.5 is independently selected at each occurrence from H, optionally substituted alkyl and optionally substituted aryl; and
(53) R.sup.8 is independently selected at each occurrence from NH.sub.2 and NH-A-NH, wherein A is selected from C.sub.1-20 aliphatic moieties, C.sub.6-10 aromatic moieties, and combinations thereof;
(54) provided that at least two occurrences, R.sup.1, R.sup.2, R.sup.3 and R.sup.4, taken together, are selected from bromo, chloro and fluoro, and further provided that when both R.sup.1 and R.sup.2 on a single ring are Cl, at least one of R.sup.3 and R.sup.4 is not Cl.
(55) In another embodiment of the present invention, the membrane may be formed following a multi layering process. The multi layering process is configured to control and to adjust a cross-linking reaction according to temperature and/or spinning speed. This process further prevents and inhibits a reaction between the polymer and the cross linker. The layering process provides coupling of a cross linker and a polymer separately such that, when first coupling, a polymer cross linking is provided, adding further layers of polymer and cross linker as demanded. This process has the advantage of producing a stable membrane in a stable and uniform process in a short time period. The process may further be embedded in the roll to roll system for minimalizing the manufacturing time. The multi layering process may further comprise the step of preparing a modification solution comprising 0.125% PEI together with about 0.04% condensate such as cyanuric chloride and sulfonilic acid at room temperature for about 2 hours in order to form, at least partially, a crosslinked PEI.
EXAMPLE 1
(56) A Nanofiltraion membrane suitable for use in accordance with embodiments of the invention was prepared in the following manner. A commercially available polysulfone or polyethersulfone PES/UF support membrane (Sepro membranes) was subjected to a cleaning step with reverse osmosis water (ROW) for 1 hour, then was immersed in aqueous solution containing 0.1% w/w of the condensate of cyanuric chloride and a sulfanilic acid for 1 hour at 70 C. After cooling and washing, the membrane was immersed in 1% polyethylenimine (PEI) solution (1% PEI, MW=750K; 1% PEI, MW=800) at room temperature (RT) and/or further followed by heat-treatment at 90 C. for 1 hour. After cooling and rinsing with ROW, the membrane was immersed in aqueous solution containing 0.1% w/w of the condensate of cyanuric chloride and a sulfanilic acid for 1 hour, then the membrane was immersed for the curing step in alkaline solution, pH 11, for 2 hours at 70 C. After this step the membrane was immersed in 0.125% polyethylenimine (PEI) solution (MW=750K) followed by heat-treatment at 90 C. for 1 hour. After cooling and rinsing with ROW, the membrane was immersed in aqueous solution containing 0.1% w/w of the condensate of cyanuric chloride and a sulfanilic acid for 1 hour, then the membrane was immersed for the curing step in alkaline solution, pH 11, for 2 hours at 70 C. After this reaction step the membrane again was immersed in 0.125% polyethylenimine (PEI) solution (MW=750K) followed by heat-treatment at 90 C. for 1 hour. After cooling and rinsing with ROW, the membrane was immersed in aqueous solution containing 0.1% w/w of the condensate of cyanuric chloride and a sulfanilic acid for 1 hour, then the membrane was immersed for the curing step in alkaline solution, pH 11, for 1 hour at 60 C. and 1 hour at 90 C. in order to order to complete the cross-linking reaction step. After rinsing the membrane with RO water the membrane was placed in 20% solution of phosphoric acid in water at 90 C. for a period of 18 hours. The membrane was removed from acid, rinsed with ROW overnight, removed and the membrane performance was measured using test cell. The membrane was found to have a flux of 92 LMH at 40 bar and 97% Glucose retention value.
(57) Analogous membranes may be prepared, for example, by substituting cyanuric fluoride or cyanuric bromide for cyanuric chloride in the condensate with sulfanilic acid or, for example by using a condensate of two substituted triazole groups with an amine bridge.
EXAMPLE 2
(58) A Nanofiltration membrane was prepared according to the procedure of Example 1 was tested to various pressures from 10 bars to 40 bars at room temperature. Flux was measured with RO water. Feed solutions for rejection test were 5%.sub.w/v glucose in RO water. The ability of the membrane to yield flux as a function of pressure and to serve retention value as illustrated in the plot of
EXAMPLE 3
(59) A Nanofiltration membrane was prepared according to the procedure of Example 1 was tested to various pressures 10, 15 and 20 bars with 3.5%.sub.w/w sodium hydroxide solution at 40 C. The ability of the membrane to yield flux as a function of pressure as shown in the plot of
EXAMPLE 4
(60)
(61) The Nanofiltration membrane was soaked in 20%.sub.w/w sodium hydroxide in water at 40 C. A set of membrane coupons was removed after 5, 20, 35, 58, 70, 92, 130 days. After each soaking period, the membrane coupons were washed with ROW and tested to flux and glucose retention at 40 bar and at room temperature. Feed solutions for rejection test were 5%.sub.w/v glucose in RO water. The flux and rejection values are given below. As the plot show, the membrane serves the initial performances after soak for long periods in 20%.sub.w/w sodium hydroxide in water at 40 C.
EXAMPLE 5
(62) A Nanofiltration membrane was prepared according to the procedure of Example 1 was soaked in 10%.sub.w/w sodium hydroxide in water at 70 C. A set of membrane coupons was removed after 260 and 450 hours. After each soaking period, the membrane coupons were tested with 0.4%.sub.w/v complex Cu(ETDA) (MW=356) in 10% w/v sodium hydroxide solution at 70 C. Percent rejection was measured by recording the UV absorbance of the feed and permeates solution at 740 nm. Then the membrane was rinsed with ROW and membrane flux was measured with ROW at RT and 70 C. The working pressure for all tests was 30 bars. The flux and rejection values are given in Table 1 below.
(63) TABLE-US-00001 TABLE 1 Complex Cu(EDTA) in 10% NaOH solution at RO water 70 C. Soaking period Flux (LMH), Flux (LMH), Rejection Flux (hrs) at 70 C. at RT (%) (LMH) 260 hrs 119 61 98 21 450 hrs 140 78 97.2 44
EXAMPLE 6
(64) A Nanofiltration membrane was prepared according to the procedure of Example 1 was soaked in 1%.sub.w/v NaAlO.sub.2 (MW=82) in 3.5%.sub.w/w sodium hydroxide solution at 40 C. for 240 hours (hrs) and then tested with 1% w/v NaAlO.sub.2 in 3.5%.sub.w/w sodium hydroxide solution at 60 C. Percent rejection was measured with UV spectrometer at 548 nm UV wavelength. The working pressure for the tests was 15 bars, VCF=5. Then the membrane was rinsed with ROW and membrane flux and rejection was measured with 2000 ppm MgSO.sub.4 in water solution at RT, 15 bars. The flux and rejection values are given in Table 2 below.
(65) TABLE-US-00002 TABLE 2 2000 ppm MgSO.sub.4 aqueous 1%.sub.w/v NaAlO.sub.2 in 3.5% NaOH solution solution Rejection (%) Flux (LMH), at RT Rejection (%) Flux (LMH) 96.6 88 85.4 42
EXAMPLE 7
(66) A Nanofiltration membrane was prepared according to the procedure of Example 1 was soaked in 20%.sub.w/w sodium hydroxide solution at 40 C. for 1500 hours. A set of membrane coupons was removed after 240 hours and tested with 0.1%.sub.w/w NaAlO.sub.2 in 3.5%.sub.w/w sodium hydroxide solution at 60 C. Percent rejection was measured with UV spectrometer at 548 nm UV wavelength. The working pressure for the tests was 15 bars, VCF=15. Then the membrane was rinsed with ROW and membrane flux and rejection was measured with 2000 ppm MgSO.sub.4 in water solution at RT, 15 bars. The flux and rejection values are given in Table 3 below.
(67) TABLE-US-00003 TABLE 3 2000 ppm MgSO.sub.4 aqueous 0.1%.sub.w/v NaAlO.sub.2 in 3.5% NaOH solution solution Rejection (%) Flux (LMH), at RT Rejection % Flux (LMH) 97.8 65 89.8 50
EXAMPLE 8
(68) A Nanofiltration membrane was prepared according to the procedure of example 1 was soaked in 1%.sub.w/w, 10%.sub.w/w and 20%.sub.w/w H.sub.2SO.sub.4 in water at 70 C. A set of membrane coupons were removed after 72 and 480 hours. After each soaking period, the membrane coupons were washed with ROW and tested to flux and glucose retention at 40 bar and room temperature. Feed solutions for rejection test were 5%.sub.w/v glucose in RO water. The flux and rejection values are given in Table 4 below.
(69) TABLE-US-00004 TABLE 4 Glucose rejection Flux (LMH) in % H.sub.2SO.sub.4 Soaking period (%) ROW solution (hrs) 97 101 1 72 97.5 92 10 97.1 108 20 96.5 91 1 480 96.8 88 10 96.7 96 20
EXAMPLE 9
(70) An NF membrane was prepared according to the procedure of Example 1, using a Polyethersulfone (PES) UF support membrane (Microdyn Nadir UP020). The membrane was found to have a flux of 80 LMH at 40 bar and 96% Glucose retention value.
(71) In accordance with another preferred embodiment of the present invention, a method of forming a polymeric semipermeable membrane stable in solvent and acid environment is presented. The polymeric semipermeable membrane stable in solvent and acid comprising steps of providing a cross-linked UF base polymer having reactive pendant moieties preferably polyacrylonitrile (PAN) and effecting a cross-linking reaction between the reactive pendant moieties on a surface of the base polymer with an oligomer or another polymer preferably polyethylenimine PEI, thereby forming a chemical bonded skin on the surface of the base polymer.
(72) In another embodiment of the present invention, a method of forming a solvent and acid stable semipermeable membrane wherein comprising the steps of: (a) providing a ultrafiltration (UF) base support membrane, (b) providing a aqueous solution containing condensate, (c) immersing the UF base support membrane in the aqueous solution containing condensate. The condensate is electrostatically or covalently bonded to the UF, (d) providing a solution comprising polyethylenimine (PEI), (e) forming at least one first layer upon the UF base support membrane by immersing the UF base support membrane comprising the condensate, in the solution comprising PEI for further functionalizing the first layer, (f) forming at least one second layer upon the first layer by immersing the first layer in a PEI with the condensate solution, thereby forming a cross-linked skin on the first layer.
(73) In another embodiment, the method additionally comprising steps of repeating at least one of the steps b, c, d, e, f n times for providing n layers, wherein n is an integer equals to or greater than 1.
(74) In another embodiment, the UF base membrane comprises cross-linked polyacrylonitrile (PAN).
(75) In another embodiment, the step of immersing the UF base support membrane in the solution comprising PEI additionally comprising step of contacting the UF support membrane with 0.1% to about 1% polyethylenimine (PEI) solution followed by heat-treatment at a temperature of about 70 to about 90 C.
(76) In another embodiment, the method additionally comprising step of forming a Nanofiltration base membrane comprising at least one di-, tri- or tetra-halo substituted diazine or triazine-containing monomer, oligomer or polymer, and at least one multifunctional amine having a molecular weight in the range of 400 to 750,000, provided that at least one of the di-, tri- or tetra-halo substituted diazine or triazine-containing monomer, oligomer or polymer is not a di- or triazine monomer which is substituted only by Cl.
(77) In another embodiment, the Nanofiltration layer comprises at least one di-, tri- or tetra-halo substituted diazine or triazine-containing monomer, oligomer or polymer, and at least one multifunctional amine having a molecular weight in the range of 400 to 750,000, provided that at least one of the di-, tri- or tetra-halo substituted diazine or triazine-containing monomer, oligomer or polymer is not a di- or triazine monomer which is substituted only by Cl.
(78) In another embodiment, the Nanofiltration membrane, when exposed to a solvent or acid environment shows more than 95% Glucose retention value. In another embodiment, the membrane after soaking the membrane in 20%.sub.w/w H.sub.2SO.sub.4 at 90 C. for a period of about 24 to 300 hours, yield more than 96% glucose rejection, (see Table 5)
(79) In another embodiment, the membrane after soaking the membrane in 100%.sub.w/w N-methylpyrrolidone (NMP) at 60 C. for a period of about 24 to 300 hrs, yield more than 96% glucose rejection, (see Table 5)
EXAMPLE 10
(80) An NF membrane was prepared according to the procedure of Example 1, but a cross-linked polyacrylonitrile (PAN) UF support membrane was instead of PES/UF support membrane (from Sepro membranes). The membrane was found to have a flux of 71 LMH at 40 bar and 97% Glucose retention value.
EXAMPLE 11
(81) A NF membrane was prepared according to the procedure of Example 10 was placed in 20%.sub.w/w H.sub.2SO.sub.4 in water at 90 C. A set of membrane coupons were removed after 24, 100 and 300 hrs. After each soaking period, the membrane coupons were washed with ROW and tested to flux and glucose retention at 40 bar and room temperature. Feed solutions for rejection test were 5%.sub.w/v glucose in RO water. The flux and rejection values are given below. As illustrated in the plot, the membrane serves the initial performances after been soaked for long periods in 20%.sub.w/w H.sub.2SO.sub.4 in water at 90 C. The flux and rejection values are given in Table 5 below.
(82) TABLE-US-00005 TABLE 5 Soaking period in 20% H.sub.2SO.sub.4, Glucose rejection Flux (lmh) in 90 C., (hrs) (%) ROW 24 97.2 88 100 96.6 96 97 94
EXAMPLE 12
(83) A NF membrane was prepared according to the procedure of Example 10 was placed in pure N-methylpyrrolidone (NMP) at 60 C. A set of membrane coupons were removed after 24, 100 and 300 hrs. After each soaking period, the membrane coupons were washed with ROW and tested to flux and glucose retention at 40 bar and room temperature. Feed solutions for rejection test were 5%.sub.w/v glucose in RO water. The flux and rejection values are given below. As the plot show, the membrane serves the initial performances after soak for long periods in pure N-methylpyrrolidone (NMP) at 60 C. The flux and rejection values are given in Table 6 below.
(84) TABLE-US-00006 TABLE 6 Soaking period in NMP, Glucose rejection Flux (lmh) in 60 C., (hrs) (%) ROW 24 97.2 69 100 97.2 67 96.7 96
EXAMPLE 13
(85) A Nanofiltraion membrane suitable for use in accordance with the embodiments of the present invention was prepared in the following manner. A commercially available PES/UF support membrane was subjected to a cleaning step with alkaline solution, pH 11 at 90 C. for 1 hour, and then with reverse osmosis water (ROW) for 30 min.
(86) A Modification solution was previously prepared as following: aqueous solution of the condensate of cyanuric chloride and a sulfanilic acid is added with stirring to aqueous solution of polyethylenimine (PEI). The solution was heated to 50 C. for 3 hour, cooled and diluted to requested concentration. The membrane was immersed in modification solution for 18 hours at a room temperature (RT), and further heated to 50 C. for 1 hour. After cooling and rinsing with ROW, the membrane was immersed in aqueous solution containing 0.1% w/w of the condensate of cyanuric chloride and a sulfanilic acid for 1 hour. The membrane was further immersed for the curing step in alkaline solution, pH 11, for 2 hours at 70 C. After cooling and rinsing with ROW, the membrane was further immersed in aqueous solution containing 0.1% w/w of the condensate of cyanuric chloride and a sulfanilic acid for 1 hour. The membrane was immersed in modification solution for 1 hour at RT following with curing step in alkaline solution, pH 11, for 2-3 hours at 60-90 C. After cooling and rinsing with ROW, the membrane was immersed in aqueous solution containing 0.1% w/w of the condensate of cyanuric chloride and a sulfanilic acid for 1 hour. The membrane was immersed for the curing step in alkaline solution, pH 11, for 2 hour at 60 C. and 2 hour at 90 C. in order to order to complete the cross-linking reaction step and was rinsing with RO water.
EXAMPLE 14
(87) A Nanofiltration membrane was prepared according to the procedure of example 13 was placed in 20% solution of phosphoric acid in water at 90 C. for a period of 18 hours. The membrane was removed from acid, rinsed with ROW overnight, removed and the membrane performance was measured using test cell. The membrane was found to have a flux of 120 LMH at 40 bar and 98% Glucose retention value.
EXAMPLE 15
(88) A Nanofiltration membrane was prepared according to the procedure of example 13 was placed in 30% solution of phosphoric acid in water at 90 C. for a period of 18 hours. The membrane was removed from acid, rinsed with ROW overnight, removed and the membrane performance was measured using test cell. The membrane was found to have a flux of 133 LMH at 40 bar and 98% Glucose retention value.
EXAMPLE 16
(89) A Nanofiltration membrane was prepared according to the procedure of example 13 was placed in 10% solution of sodium hydroxide in water at 70 C. for a period of 64 hours. The membrane was removed from sodium hydroxide, rinsed with ROW overnight, removed and the membrane performance was measured using test cell. The membrane was found to have a flux of 133 LMH at 40 bar and 98% Glucose retention value.
EXAMPLE 17
(90) A Nanofiltration membrane was prepared according to the procedure of example 13 was placed in 10% solution of sodium hydroxide in water at 70 C. for a period of 240 hours. The membrane was removed from sodium hydroxide, rinsed with ROW overnight, removed and the membrane performance was measured using test cell. The membrane was found to have a flux of 135 LMH at 40 bar and 98% Glucose retention value.
EXAMPLE 18
(91) A Nanofiltration membrane was prepared according to the procedure of example 14 was placed in 10% solution of sodium hydroxide in water at 70 C. for a period of 54 hours. The membrane was removed from sodium hydroxide, rinsed with ROW overnight, removed and the membrane performance was measured using test cell. The membrane was found to have a flux of 150 LMH at 40 bar and 97% Glucose retention value.
EXAMPLE 19
(92) A Nanofiltration membrane was prepared according to the procedure of example 15 was placed in 10% solution of sodium hydroxide in water at 70 C. for a period of 54 hours. The membrane was removed from sodium hydroxide, rinsed with ROW overnight, removed and the membrane performance was measured using test cell. The membrane was found to have a flux of 166 LMH at 40 bar and 97% Glucose retention value.
EXAMPLE 20
(93) A NF membrane was prepared according to the procedure of Example 13, but a cross-linked polyacrylonitrile (PAN) UF support membrane was instead of PES/UF support membrane (from Sepro membranes). The membrane was found to have a flux of 80 LMH at 40 bar and 98% for MgSO.sub.4 retention value in 2000 ppm MgSO.sub.4 solution.
EXAMPLE 21
(94) An NF membrane prepared according to the procedure of example 8 was placed in 20%.sub.w/w H.sub.2SO.sub.4 in water at 90 C. A set of coupons were removed after 24, 100, 360 and 600 hrs. After each soaking period, the coupons were washed with ROW and tested to flux and MgSO.sub.4 retention at 40 bar and room temperature. Feed solutions for rejection test were with 2000 ppm MgSO.sub.4 solution. The flux and rejection values are given below. As the plot show, the membrane serves the initial performances after soak for long periods in 20%.sub.w/w H.sub.2SO.sub.4 in water at 90 C. The flux and rejection values are given in Table 7 below.
(95) TABLE-US-00007 TABLE 7 Flux (lmh) in MgSO.sub.4 rejection Soaking period in 20% ROW (%) H.sub.2SO.sub.4, 90 C., (hrs) 60 98 24 57 95 100 64 95 360 70 95 600
(96) In the foregoing description, embodiments of the invention, including preferred embodiments, have been presented for the purpose of illustration and description. They are not intended to be exhaustive or to limit the invention to the precise form disclosed. Obvious modifications or variations are possible in light of the above teachings. The embodiments were chosen and described to provide the best illustration of the principals of the invention and its practical application, and to enable one of ordinary skill in the art to utilize the invention in various embodiments and with various modifications as are suited to the particular use contemplated. All such modifications and variations are within the scope of the invention as determined by the appended claims when interpreted in accordance with the breadth they are fairly, legally, and equitably entitled.